Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand

Head and neck cancer (HNC) accounts for more than 330,000 cancer deaths annually worldwide. Despite late diagnosis being a major factor contributing to HNC mortality, no satisfactory biomarkers exist for early disease detection. Cytoplasmic gelsolin (cGSN) was discovered to predict disease progressi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen-Tzu Chiu, Pei-Wen Wang, Meshach Asare-Werehene, Benjamin K. Tsang, Dar-Bin Shieh
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-06-01
Colecção:Cancers
Assuntos:
plasma gelsolin
sFasL
circulating biomarker
head and neck cancer
diagnosis
Acesso em linha:https://www.mdpi.com/2072-6694/12/6/1569
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados